Winter 2014 2015
This issue sponsored by the Southeast Lipid Association Featuring: "Translating Clinical Trial Evidence into Practical Medicine" and "Guidelines for the Guidelines — Impact and Controversies" more
I have in mind a prospective clinical trial in which I study a common children’s phenomenon, detailing the differences between genders, location, ethnicity, biometrics, dental data, monetary value, etc. It’s a common phenomenon that most parents have photos of and have experienced ourselves. I’m... more
The Heart Protection Study 2 — Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) trial was a randomized, double-blind, multicenter clinical trial.1 Enrolled subjects were between ages 50 and 80 and had a history of vascular disease. After a four-week run-in phase with... more
Blood Lipid Response to Physical Activity and Exercise Training A prevailing myth among patients and many healthcare providers is the notion that physical exercise “burns” or oxidizes cholesterol or cholesterol-rich particles similar to the utilization of fatty acids and glucose. This doesn’t... more
Atherogenic lipoproteins play a critical role in the initiation and progression of vascular atherosclerosis, and decades of research have clearly demonstrated the benefits of lipid-lowering therapy for prevention of atherosclerotic cardiovascular disease (ASCVD) events. However, despite the... more
Case: The patient was a 62-year-old Caucasian woman when she was first seen at the Florida Lipid Institute in 2010. She had hypertension that was treated with losartan/HCTZ. She had no other significant past medical history. She had a family history of hypertension and diabetes and one brother... more
It was an honor and privilege for the Southeast Lipid Association (SELA) to host the National Lipid Association (NLA) Scientific Sessions in Orlando, Fla. this past May 2014. Excellent topics and presenters offered practical knowledge for integrating the latest clinical research guidelines into... more
“Security is mostly a superstition. It does not exist in nature, nor do the children of men as whole experience it. Avoiding danger is no safer in the long run than outright exposure. Life is either a daring adventure or nothing.” – Helen Keller This quote is a favorite of Deborah S. Croy, DNP.... more
I hope everyone had a wonderful Holiday Season and a Happy New Year! To kick off the New Year, the Foundation of the National Lipid Association (FNLA) is hard at work with new projects and partnerships. Most recently, the FNLA collaborated with Sanofi US and Regeneron Pharmaceuticals Inc. in... more
Greetings, National Lipid Association members! I hope this holiday season has been a joyous one. As we look back on 2014, we can reflect on the many accomplishments the NLA has put forth. And, as we look toward the New Year, we are encouraged for what’s to come — both for the NLA as a... more